ArticleFuture medicinal chemistry2011

Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite.

Thomas Seebeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.